MedicaidPrior AuthMedium impact
2021-03 Policy Updates and Changes to Clinical Review Criteria pdf
Connecticut Medicaid (HUSKY Health)·CT · Neurology, Pediatrics, ENT (Ear, Nose & Throat) +1 more·Provider Bulletin
Effective date
Feb 1, 2021
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid is implementing new prior authorization policies for three Duchenne Muscular Dystrophy treatments (Eteplirsen, Golodirsen, Viltolarsen), removing prior auth requirements for Supprelin LA, simplifying compression garment requests by eliminating measurement requirements, and switching BAHA reviews to InterQual criteria. All changes are effective February 1, 2021.
Action Required
By February 1, 2021: Billing team must download new prior authorization forms for Eteplirsen, Golodirsen, and Viltolarsen from the HUSKY Health website (https://portal.ct.gov/husky). Remove prior authorization requirements for Supprelin LA from billing system. Update compression garment prior auth requests to exclude measurements. Contact CHNCT at 1-800-440-5071 for prior authorization process questions.